Related Experiment Video
Updated: May 4, 2026

11:00
High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
11.9K
Handheld RPA-based molecular POCT system for rapid, low-cost 8-plexed detection of respiratory pathogens at home
Yunfeng Zai1,2, Chao Min2, Zunliang Wang1
1State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Si Pai Lou 2, Nanjing 210096, China. zlwang@seu.edu.cn.
Lab on a Chip
|May 8, 2025
Summary
A new microfluidic system uses recombinase polymerase amplification (RPA) for rapid, multiplexed home testing of respiratory pathogens. This cost-effective, user-friendly device enables early diagnosis of infections, improving public health outcomes.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Point-of-Care Testing
Background:
- Rapid diagnosis of respiratory pathogens is critical during outbreaks.
- Existing point-of-care testing (POCT) systems are often complex and costly for home use.
- Need for accessible, user-friendly home-based molecular diagnostic tools.
Purpose of the Study:
- To develop a novel microfluidic cartridge-based system for multiplexed home-based detection of respiratory pathogens.
- To overcome limitations of current POCT systems for home use.
- To enable rapid, accurate, and cost-effective diagnosis of respiratory infections in non-clinical settings.
Main Methods:
- A microfluidic cartridge with three parallel channels was designed, integrating lysis, RPA, and air storage chambers.
- Extraction-free, 3-plex recombinase polymerase amplification (RPA) assays were performed in each channel.
- A pneumatic pressure pumping strategy with hydraulic resistance matching ensured precise flow control and uniform reagent distribution.
- A dynamic mixing method facilitated homogeneous mixing of samples and reagents.
Main Results:
- The system achieved simultaneous identification of eight respiratory pathogens and one internal control in under 25 minutes.
- The microfluidic system is compact (<1 kg), lightweight, and has low power consumption (3 W).
- The cost per test is remarkably low ($1.4), enhancing accessibility.
- Validation with 356 nasopharyngeal swabs demonstrated high sensitivity (>97%) and specificity (>99%).
Conclusions:
- The developed microfluidic system offers a practical and accessible solution for home-based multiplexed molecular POCT.
- It enables reliable, rapid, and cost-effective diagnosis of respiratory co-infections.
- The system's user-friendliness and performance characteristics make it suitable for vulnerable populations and home environments.

